Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Silo Pharma, Inc. (SILO)
USD4.88
-0.26 (-4.97%)
US NASDAQ Healthcare Biotechnology
Address
677 N. Washington Boulevard 34236
Sarasota, FL, US
Sarasota, FL, US
CEO
Eric Weisblum
Website
silopharma.com
IPO
2021-01-08
CIK 1514183 ISIN US82711P3001
Description
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.
News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.88
-0.26 (-4.97%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
298.2K
Beta
0.75
Float Shares
7.65M
Free Float %
95.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.95% | -4.00% | -1.50% | +35.40% | -4.65% | +15.88% | -52.87% | -81.15% | -97.37% | -97.75% | -97.75% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
4.88
DCF (Unlevered)
0.43
-91.2%
DCF (Levered)
0.42
-91.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-172.80
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+0.0% Q1'26: +0.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+58.0% ★ Q1'26: +47.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-7,630.8% Q1'26: -4,563.5% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-5,937.0% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+127.8% Q1'26: +205.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
72.1K
est: 70.0K (+3.0%)
|
72.1K
est: 72.0K (+0.1%)
|
72.1K
est: 72.0K (+0.1%)
|
72.0K
72.0K – 72.0K
+0.0% YoY
|
72.0K
72.0K – 72.0K
+0.0% YoY
|
72.0K
72.0K – 72.0K
+0.0% YoY
|
| EBITDA |
-3.63M
est: -14.0K (-25,803.4%)
|
-4.38M
est: -43.2K (-10,042.6%)
|
-4.28M
est: -43.2K (-9,808.9%)
|
-43.2K
-43.2K – -43.2K
+0.0% YoY
|
-43.2K
-43.2K – -43.2K
+0.0% YoY
|
-43.2K
-43.2K – -43.2K
+0.0% YoY
|
| EBIT |
-3.63M
est: -14.0K (-25,803.4%)
|
-4.39M
est: -43.2K (-10,056.9%)
|
-4.28M
est: -43.2K (-9,808.9%)
|
-43.2K
-43.2K – -43.2K
+0.0% YoY
|
-43.2K
-43.2K – -43.2K
+0.0% YoY
|
-43.2K
-43.2K – -43.2K
+0.0% YoY
|
| Net Income |
-3.70M
est: -3.75M (+1.4%)
|
-4.39M
est: -4.69M (+6.4%)
|
-4.23M
est: -5.87M (+27.9%)
|
-6.04M
-6.04M – -6.04M
-2.9% YoY
|
-9.39M
-9.39M – -9.39M
-55.6% YoY
|
-10.14M
-10.14M – -10.14M
-8.0% YoY
|
| SGA |
3.08M
est: 1.99M (+54.3%)
|
2.40M
est: 2.47M (-2.5%)
|
2.15M
est: 2.47M (-12.9%)
|
2.47M
2.47M – 2.47M
+0.0% YoY
|
2.47M
2.47M – 2.47M
+0.0% YoY
|
2.47M
2.47M – 2.47M
+0.0% YoY
|
| EPS |
-1.20
est: -1.02 (-17.6%)
|
-1.19
est: -0.56 (-112.5%)
|
-0.50
est: -0.70 (+28.6%)
|
-0.72
-0.72 – -0.72
-2.9% YoY
|
-1.12
-1.12 – -1.12
-55.6% YoY
|
-1.21
-1.21 – -1.21
-8.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
3
Total invested
243.4K
Insider transactions (90d)
0
Beneficial owners (>5%)
16
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Melvin Schlossberg | 20.00M | 65.30% | 20.00M | — | 20.00M | 10.00 | IN | United States | 2013-01-07 | ↗ |
| 2 | Michael Finkelstein | 5.52M | 18.00% | — | 5.52M | — | 10.00 | IN | Canada | 2012-12-27 | ↗ |
| 3 | Whalehaven Capital Fund Limited | 5.52M | 18.00% | — | 5.52M | — | 10.00 | CO | BERMUDA | 2012-12-27 | ↗ |
| 4 | Wilfong | 5.39M | 6.50% | 5.39M | — | 5.39M | — | IN | United States | 2020-05-21 | ↗ |
| 5 | Eric Weisblum | 3.58M | 11.66% | 3.58M | — | 3.58M | — | IN | United States | 2013-07-15 | ↗ |
| 6 | Richard A. Brand | 2.04M | 6.65% | 2.04M | — | 2.04M | — | IN | United States | 2013-07-15 | ↗ |
| 7 | R | 313.7K | 9.99% | 307.9K | 5.8K | 307.9K | 5.8K | IN | U.S. | 2022-11-16 | ↗ |
| 8 | Daniel B. Asher | 235.5K | 4.99% | — | 235.5K | — | 235.5K | HC, IN | United States of America | 2024-07-26 | ↗ |
| 9 | Intracoastal Capital LLC | 235.5K | 4.99% | — | 235.5K | — | 235.5K | OO | United States of America | 2024-07-26 | ↗ |
| 10 | Mitchell P. Kopin | 235.5K | 4.99% | — | 235.5K | — | 235.5K | HC, IN | United States of America | 2024-07-26 | ↗ |
| 11 | The Special Equities Opportunity Fund, LLC | 5.4K | 0.19% | 5.4K | — | 5.4K | — | OO | U.S. | 2022-11-16 | ↗ |
| 12 | Joseph Reda C/F Angus Patrick Deeney UTMA/NY | 1.0K | 0.03% | 1.0K | — | 1.0K | — | OO | U.S. | 2022-11-16 | ↗ |
| 13 | Joseph Reda C/F Claire Estie Deeney UTMA/NY | 1.0K | 0.03% | 1.0K | — | 1.0K | — | OO | U.S. | 2022-11-16 | ↗ |
| 14 | Joseph Reda C/F Dustin Russell Reda UTMA/NY | 1.0K | 0.03% | 1.0K | — | 1.0K | — | OO | U.S. | 2022-11-16 | ↗ |
| 15 | Joseph Reda C/F Joseph William Reda UTMA/NY | 1.0K | 0.03% | 1.0K | — | 1.0K | — | OO | U.S. | 2022-11-16 | ↗ |
| 16 | High River Limited Partnership | 468.00 | 3.40% | 3.06M | — | 3.06M | — | PN | Liechtenstein | 2018-07-30 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
3
-12 vs prev Q
New positions
2
Closed positions
14
Increased
3
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ADVISORSHARES INVESTMENTS LLC | 599.5K +234.6K (+64.3%) | 203.8K -47.9K (-19.0%) | 6.42% +0.614 pp | 0.03% -0.007 pp | USD0.65 -47.7% | 4 qtrs — |
| 2 | DRW SECURITIES, LLC | 333.7K +333.7K (+100.0%) | 113.5K +113.5K (+100.0%) | 3.58% +3.577 pp | 0.00% +0.003 pp | USD0.34 +0.0% | 1 qtrs NEW |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 92.9K +53.3K (+134.6%) | 31.6K +4.3K (+15.6%) | 1.00% +0.365 pp | 0.00% +0.000 pp | USD0.81 -58.0% | 12 qtrs — |
| 4 | XTX TOPCO LTD | 56.9K +56.9K (+100.0%) | 19.3K +19.3K (+100.0%) | 0.61% +0.610 pp | 0.00% +0.001 pp | USD0.34 +0.0% | 5 qtrs — |
| 5 | JANE STREET GROUP, LLC | 34.4K +17.6K (+104.9%) | 11.7K +114.0 (+1.0%) | 0.37% +0.101 pp | 0.00% +0.000 pp | USD0.51 -33.3% | 2 qtrs — |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 29.6K +29.6K (+100.0%) | 10.1K +10.1K (+100.0%) | 0.32% +0.317 pp | 0.00% +0.000 pp | USD0.34 +0.0% | 1 qtrs NEW |
| 7 | VANGUARD GROUP INC | 24.3K +8.0K (+48.9%) | 8.3K -3.0K (-26.6%) | 0.26% +0.001 pp | 0.00% +0.000 pp | USD1.22 -72.1% | 10 qtrs — |
| 8 | VIRTU FINANCIAL LLC | 18.4K -89.4K (-82.9%) | 6.0K -68.0K (-91.9%) | 0.20% -1.519 pp | 0.00% -0.004 pp | USD0.69 -50.7% | 2 qtrs — |
| 9 | STATE STREET CORP | 12.5K +— (+0.0%) | 4.3K -4.4K (-50.7%) | 0.13% -0.065 pp | 0.00% +0.000 pp | USD2.10 -83.8% | 12 qtrs — |
| 10 | UBS GROUP AG | 6.0K -2.9K (-32.7%) | 2.1K -4.1K (-66.9%) | 0.06% -0.078 pp | 0.00% +0.000 pp | USD0.69 -50.7% | 2 qtrs — |
| 11 | CITIGROUP INC | 3.5K +3.5K (+100.0%) | 1.2K +1.2K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.000 pp | USD0.34 +0.0% | 5 qtrs — |
| 12 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.7K -12.0 (-0.7%) | 576.00 -602.0 (-51.1%) | 0.02% -0.009 pp | 0.00% +0.000 pp | USD1.46 -76.7% | 13 qtrs — |
| 13 | BANK OF AMERICA CORP /DE/ | 114.00 +35.0 (+44.3%) | 38.00 -17.0 (-30.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.67 -49.3% | 7 qtrs — |
| 14 | WESTSIDE INVESTMENT MANAGEMENT, INC. | 94.00 +— (+0.0%) | 32.00 -33.0 (-50.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.10 -83.8% | 12 qtrs — |
| 15 | WELLS FARGO & COMPANY/MN | 10.00 +— (+0.0%) | 3.00 -4.0 (-57.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.60 -43.3% | 2 qtrs — |
| 16 | ANSON FUNDS MANAGEMENT LP | — -952.4K (-100.0%) | — -657.1K (-100.0%) | 0.00% -15.166 pp | 0.00% -0.060 pp | USD— | 2 qtrs SOLD |
| 17 | STONEX GROUP INC. | — -13.4K (-100.0%) | — -9.3K (-100.0%) | 0.00% -0.214 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 18 | TWO SIGMA SECURITIES, LLC | — -16.5K (-100.0%) | — -11.4K (-100.0%) | 0.00% -0.262 pp | 0.00% -0.002 pp | USD— | 5 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | AdvisorShares Psychedelics ETF PSIL | 0.97% | 430.7K | 1.84% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 75.0K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
19.0K
Shares disposed
—
Cash buys
6.00
Cash sales
—
Net activity
+19,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-15 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.42 | 1.1K | 216,932 | D | ↗ |
| 2025-11-21 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 0.37 | 365.00 | 211,932 | D | ↗ |
| 2025-11-20 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 0.37 | 370.00 | 210,932 | D | ↗ |
| 2025-11-19 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 4,500 | 0.41 | 1.8K | 209,932 | D | ↗ |
| 2025-11-18 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 7,500 | 0.40 | 3.0K | 205,432 | D | ↗ |
| 2025-05-27 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.43 | 4.3K | 197,932 | D | ↗ |
| 2025-05-23 | Weisblum Eric | Director / Officer | A-Award | A | Options (right to buy) | 200,000 | 0.43 | 85.8K | 387,932 | D | ↗ |
| 2025-05-23 | Ryweck Daniel E. | Officer | A-Award | A | Options (right to buy) | 50,000 | 0.43 | 21.5K | 55,000 | D | ↗ |
| 2025-05-23 | Pavell Jeff | Director | A-Award | A | Options (right to buy) | 50,000 | 0.43 | 21.5K | 50,000 | D | ↗ |
| 2025-05-23 | Munoz Kevin | Director | A-Award | A | Options (right to buy) | 50,000 | 0.43 | 21.5K | 53,425 | D | ↗ |
| 2025-05-23 | Linsley Wayne | Director | A-Award | A | Options (right to buy) | 50,000 | 0.43 | 21.5K | 53,425 | D | ↗ |
| 2024-12-13 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.84 | 2.1K | 187,932 | D | ↗ |
| 2024-11-22 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.90 | 2.3K | 185,432 | D | ↗ |
| 2024-11-20 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.95 | 2.4K | 182,932 | D | ↗ |
| 2024-06-12 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 4,438 | 1.11 | 4.9K | 180,432 | — | ↗ |
| 2024-06-11 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 562 | 1.08 | 606.96 | 175,994 | — | ↗ |
| 2024-04-05 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 400 | 2.03 | 812.00 | 175,432 | — | ↗ |
| 2024-04-04 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 600 | 1.96 | 1.2K | 175,032 | — | ↗ |
| 2024-04-01 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 1,100 | 1.91 | 2.1K | 174,432 | — | ↗ |
| 2024-03-28 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 3,408 | 1.94 | 6.6K | 173,332 | — | ↗ |
| 2023-12-20 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 200 | 1.61 | 322.00 | 169,924 | — | ↗ |
| 2023-12-19 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 500 | 1.63 | 815.00 | 169,724 | — | ↗ |
| 2023-12-15 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 900 | 1.52 | 1.4K | 169,224 | — | ↗ |
| 2023-12-14 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 200 | 1.50 | 300.00 | 168,324 | — | ↗ |
| 2023-12-07 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 324 | 1.36 | 440.64 | 168,124 | — | ↗ |
| 2023-12-06 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 76 | 1.34 | 101.84 | 167,800 | — | ↗ |
| 2023-12-05 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 600 | 1.39 | 834.00 | 167,724 | — | ↗ |
| 2023-11-30 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.53 | 1.5K | 167,124 | — | ↗ |
| 2023-11-29 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.57 | 1.6K | 166,124 | — | ↗ |
| 2023-11-27 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 250 | 1.78 | 445.00 | 165,124 | — | ↗ |
| 2023-11-22 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 400 | 1.68 | 672.00 | 164,874 | — | ↗ |
| 2023-11-21 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 300 | 1.56 | 468.00 | 164,474 | — | ↗ |
| 2023-11-20 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 4,050 | 1.60 | 6.5K | 164,174 | — | ↗ |
| 2023-11-17 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 1,800 | 1.54 | 2.8K | 160,124 | — | ↗ |
| 2023-11-16 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 1,100 | 1.33 | 1.5K | 158,324 | — | ↗ |
| 2023-05-26 | Ryweck Daniel E. | Officer | P-Purchase | A | Common Stock | 1,000 | 2.13 | 2.1K | 5,000 | — | ↗ |
| 2023-05-18 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 500 | 2.11 | 1.1K | 157,724 | — | ↗ |
| 2023-05-17 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 2.06 | 5.2K | 157,224 | — | ↗ |
| 2022-12-20 | Weisblum Eric | Officer | P-Purchase | A | Common Stock | 130 | 2.72 | 353.60 | 154,854 | — | ↗ |
| 2022-12-19 | Weisblum Eric | Officer | P-Purchase | A | Common Stock | 200 | 2.68 | 536.30 | 154,724 | — | ↗ |
| 2022-12-14 | Weisblum Eric | Officer | P-Purchase | A | Common Stock | 263 | 3.17 | 833.68 | 154,524 | — | ↗ |
| 2022-12-13 | Weisblum Eric | Officer | P-Purchase | A | Common Stock | 487 | 3.07 | 1.5K | 154,261 | — | ↗ |
| 2022-09-27 | Ryweck Daniel E. | Officer | — | D | Common Stock | 0 | 0.00 | — | 4,000 | — | ↗ |
| 2022-09-27 | Pavell Jeff | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-17 | Weisblum Eric | Officer | P-Purchase | A | Common Stock | 13,080 | 0.11 | 1.5K | 7,724,643 | — | ↗ |
| 2021-12-29 | Munoz Kevin | Director | A-Award | A | Non-Qualified Stock Option | 171,233 | 0.15 | 25.0K | 171,233 | — | ↗ |
| 2021-12-29 | Linsley Wayne | Director | A-Award | A | Non-Qualified Stock Option | 171,233 | 0.15 | 25.0K | 171,233 | — | ↗ |
| 2021-12-13 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 17,500 | 0.14 | 2.4K | 7,711,563 | — | ↗ |
| 2021-12-10 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.16 | 777.00 | 7,694,063 | — | ↗ |
| 2020-10-01 | Munoz Kevin | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-04-28 | Weisblum Eric | Director / Officer | A-Award | A | Common Stock | 7,630,949 | 0.00 | — | 7,689,063 | — | ↗ |
| 2020-04-17 | Weisblum Eric | Director / Officer | A-Award | A | Common Stock | 7,630,949 | 0.00 | — | 7,988,663 | — | ↗ |
| 2020-01-16 | Linsley Wayne | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-10-22 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 200 | 0.45 | 90.00 | 58,114 | — | ↗ |
| 2019-10-15 | Weisblum Eric | Director / Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 0.00 | 10.00 | 100,000 | — | ↗ |
| 2019-06-17 | Weisblum Eric | Director / Officer | P-Purchase | A | Common Stock | 57,714 | 0.00 | 115.43 | 57,714 | — | ↗ |
| 2016-02-10 | Parker Van Eps | Director | J-Other | D | Stock option | 112,500 | 0.00 | — | 0 | — | ↗ |
| 2015-07-23 | WASSERMAN ADAM C | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-01-01 | Stone, Joel Alan | Director | J-Other | A | Stock option (right to buy) | 112,500 | 0.30 | 33.8K | 0 | — | ↗ |
| 2015-01-01 | SCHILLER LEONARD M | Director | J-Other | A | Stock option (right to buy) | 112,500 | 0.30 | 33.8K | 0 | — | ↗ |
| 2015-01-01 | Parker Walter Van Eps | Director | J-Other | A | Stock option (right to buy) | 112,500 | 0.30 | 33.8K | 0 | — | ↗ |
| 2014-09-04 | Weisblum Eric | Director / Officer | G-Gift | D | Common Stock | 3,584,160 | 1.00 | 3.58M | 0 | — | ↗ |
| 2014-07-30 | Stone, Joel Alan | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2014-07-30 | SCHILLER LEONARD M | Director | — | D | Common Stock | 0 | 0.00 | — | 37,500 | — | ↗ |
| 2014-07-30 | Parker Walter Van Eps | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-01-28 | Weisblum Eric | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-06-20 | Weisblum Eric | Director / Officer | A-Award | A | Common Stock | 3,584,160 | 0.00 | 35.84 | 3,584,160 | — | ↗ |
| 2013-06-20 | Brand Richard | Director / Officer | A-Award | A | Common Stock | 2,042,080 | 0.00 | 20.42 | 2,042,080 | — | ↗ |
| 2013-01-28 | Parker Walter Van Eps | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-01-28 | Brand Richard | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-11-29 | WHALEHAVEN CAPITAL FUND LTD | 10% Owner | — | D | COMMON STOCK | 0 | 0.00 | — | 5,519,700 | — | ↗ |
| 2011-07-20 | Schlossberg Melvin | Director / Officer / 10% Owner | — | D | COMMON STOCK | 0 | 0.00 | — | 20,000,000 | — | ↗ |
| 2011-07-20 | Ptalis Donald | Director / Officer | — | D | COMMON STOCK | 0 | 0.00 | — | 500,000 | — | ↗ |
| 2011-07-20 | MATS VADIM | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-14.3K
Shares Outstanding
8.01M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Eric Weisblum, Chief Executive Officer | 350.0K | 200.0K | — | — | — | 80.1K | 630.1K | 0.00% | ↗ |
| 2 | 2024 | Daniel Ryweck, Chief Financial Officer | 60.0K | 25.0K | — | — | — | 3.6K | 88.6K | 0.00% | ↗ |
| 3 | 2023 | Eric Weisblum, Chief Executive Officer | 350.2K | 200.0K | — | — | — | 18.9K | 569.0K | 0.00% | ↗ |
| 4 | 2023 | Daniel Ryweck, Chief Financial Officer (since September 28, 2022) | 59.9K | — | — | — | — | 2.8K | 62.7K | 0.00% | ↗ |
| 5 | 2023 | Daniel Ryweck, Chief Financial Officer | 59.9K | — | — | — | — | 2.8K | 62.7K | 0.00% | ↗ |
| 6 | 2022 | Eric Weisblum, Chief Executive Officer | 222.5K | 100.0K | — | — | — | 9.8K | 332.3K | 0.00% | ↗ |
| 7 | 2022 | Daniel Ryweck, Chief Financial Officer (since September 28, 2022) | 15.0K | — | — | — | — | — | 15.0K | 0.00% | ↗ |
| 8 | 2021 | Eric Weisblum, Chief Executive Officer | 175.0K | 170.0K | — | — | — | — | 345.0K | 0.00% | ↗ |
| 9 | 2014 | Richard Brand CEO and Chairman | — | — | — | — | — | — | — | — | ↗ |
| 10 | 2014 | Melvin Schlossberg CEO, President, Secretary and Chairman | — | — | — | — | — | — | — | — | ↗ |
| 11 | 2013 | Richard Brand CEO and Chairman | — | — | — | — | — | — | — | — | ↗ |
| 12 | 2013 | Melvin Schlossberg CEO, President, Secretary and Chairman | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Eric Weisblum | Chairman, President & Chief Executive Officer | 438.0K | male |
| Daniel E. Ryweck | Chief Financial Officer | 88.5K | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SILO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
